MEOH Stock Analysis: Methanex | NASDAQ
Chemicals | NASDAQ, USA | Market Cap: 4.240m USD | 12M Return: 67.1% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 46.2M
EPS Trend: -2.3%
Qual. Beats: 0
Rev. Trend: -64.7%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Methanex Corporation (NASDAQ: MEOH) is a Canadian-headquartered commodity chemicals producer that manufactures and sells methanol and ammonia to chemical and petrochemical customers across Asia Pacific, North America, Europe, and South America. Incorporated in 1968 and based in Vancouver, the company supplements its production operations with owned and leased in-region storage and terminal facilities, supporting global distribution to its downstream customers.
The company operates within the Materials sector (Commodity Chemicals sub-industry). Methanol is a key industrial feedstock used to produce formaldehyde, acetic acid, olefins, and various fuels and fuel additives, while ammonia is primarily consumed by the agricultural fertilizer industry. Methanexs vertically integrated production-to-terminal model is designed to deliver consistent supply to international customers, a structural feature of large-scale methanol producers.
- Methanol spot prices rise on Chinese MTO demand
- Natural gas feedstock costs pressure production margins
- Geismar plant restart adds North American supply
| Net Income: -44.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -2.41 > 1.0 |
| NWC/Revenue: 20.03% < 20% (prev 37.22%; Δ -17.20% < -1%) |
| CFO/TA 0.09 > 3% & CFO 663.2m > Net Income -44.8m |
| Net Debt (3.85b) to EBITDA (725.8m): 5.30 < 3 |
| Current Ratio: 1.96 > 1.5 & < 3 |
| Outstanding Shares: last quarter (77.3m) vs 12m ago 14.56% < -2% |
| Gross Margin: 21.72% > 18% (prev 22.88%; Δ -1.16% > 0.5%) |
| Asset Turnover: 52.80% > 50% (prev 55.59%; Δ -2.80% > 0%) |
| Interest Coverage Ratio: 1.19 > 6 (EBIT TTM 266.0m / Interest Expense TTM 224.3m) |
| A: 0.10 (Total Current Assets 1.50b - Total Current Liabilities 767.1m) / Total Assets 7.23b |
| B: 0.23 (Retained Earnings 1.63b / Total Assets 7.23b) |
| C: 0.04 (EBIT TTM 266.0m / Avg Total Assets 6.94b) |
| D: 0.53 (Book Value of Equity 2.42b / Total Liabilities 4.52b) |
| Altman-Z'' = 2.22 = BBB |
| DSRI: 1.29 (Receivables 507.5m/396.9m, Revenue 3.67b/3.70b) |
| GMI: 1.05 (GM 22.88% / 21.72%) |
| AQI: 1.10 (AQ_t 0.08 / AQ_t-1 0.07) |
| SGI: 0.99 (Revenue 3.67b / 3.70b) |
| TATA: -0.10 (NI -44.8m - CFO 663.2m) / TA 7.23b) |
| Beneish M = -2.70 (Cap -4..+1) = A |
As of July 23, 2026, the stock is trading at USD 56.45 with a total of 813,486 shares traded. Over the past week, the price has changed by +3.81%, over one month by +6.93%, over three months by -5.76% and over the past year by +67.10%.
Current recommended Stop Loss: 53.80 (which is 4.7% or 1.3 ATR below the current price).
Methanex has received a consensus analysts rating of 4.22. Therefore, it is recommended to buy MEOH.
- StrongBuy: 4
- Buy: 3
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 70.7 | 25.2% |
P/E Forward = 6.1881
P/S = 1.1565
P/B = 1.7097
P/EG = 0.1982
Revenue TTM = 3.67b USD
EBIT TTM = 266.0m USD
EBITDA TTM = 725.8m USD
Long Term Debt = 2.65b USD (from longTermDebt, last quarter)
Short Term Debt = 174.6m USD (from shortTermDebt, last quarter)
Debt = 4.23b USD (from shortLongTermDebtTotal, last quarter) + Leases 761.6m
Net Debt = 3.85b USD (calculated: Debt 4.23b - CCE 380.3m)
Enterprise Value = 8.09b USD (4.24b + Debt 4.23b - CCE 380.3m)
Interest Coverage Ratio = 1.19 (Ebit TTM 266.0m / Interest Expense TTM 224.3m)
EV/FCF = 13.72x (Enterprise Value 8.09b / FCF TTM 589.3m)
FCF Yield = 7.29% (FCF TTM 589.3m / Enterprise Value 8.09b)
FCF Margin = 16.07% (FCF TTM 589.3m / Revenue TTM 3.67b)
Net Margin = -1.22% (Net Income TTM -44.8m / Revenue TTM 3.67b)
Gross Margin = 21.72% ((Revenue TTM 3.67b - Cost of Revenue TTM 2.87b) / Revenue TTM)
Gross Margin QoQ = 20.87% (prev 20.47%)
Tobins Q-Ratio = 1.12 (Enterprise Value 8.09b / Total Assets 7.23b)
Interest Expense / Debt = 5.31% (Interest Expense 224.3m / Debt 4.23b)
Taxrate = 48.30% (2.99m / 6.18m)
NOPAT = 137.5m (EBIT 266.0m * (1 - 48.30%))
Current Ratio = 1.96 (Total Current Assets 1.50b / Total Current Liabilities 767.1m)
Debt / Equity = 1.75 (Debt 4.23b / totalStockholderEquity, last quarter 2.42b)
Debt / EBITDA = 5.30 (Net Debt 3.85b / EBITDA 725.8m)
Debt / FCF = 6.53 (Net Debt 3.85b / FCF TTM 589.3m)
Total Stockholder Equity = 2.51b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.65% (Net Income -44.8m / Total Assets 7.23b)
RoE = -1.78% (Net Income TTM -44.8m / Total Stockholder Equity 2.51b)
RoCE = 5.15% (EBIT 266.0m / Capital Employed (Equity 2.51b + L.T.Debt 2.65b))
RoIC = 2.13% (NOPAT 137.5m / Invested Capital 6.46b)
WACC = 6.48% (E(4.24b)/V(8.47b) * Re(10.20%) + D(4.23b)/V(8.47b) * Rd(5.31%) * (1-Tc(0.48)))
Discount Rate = 10.20% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 80.36 | Cagr: 6.19%
[DCF] Terminal Value 73.10% ; FCFF base≈634.6m ; Y1≈556.5m ; Y5≈449.6m
[DCF] Fair Price = 43.57 (EV 7.22b - Net Debt 3.85b = Equity 3.37b / Shares 77.4m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -2.30 | EPS CAGR: -1.04% | SUE: -0.24 | # QB: 0
Revenue Correlation: -64.66 | Revenue CAGR: -2.21% | SUE: -0.06 | # QB: 0
EPS current Quarter (2026-06-30): EPS=3.97 | Chg30d=+0.23% | Revisions=-40% | Analysts=8
EPS next Quarter (2026-09-30): EPS=2.75 | Chg30d=+1.89% | Revisions=+40% | Analysts=7
EPS current Year (2026-12-31): EPS=9.24 | Chg30d=+0.12% | Revisions=+40% | GrowthEPS=+355.1% | GrowthRev=+36.9%
EPS next Year (2027-12-31): EPS=5.29 | Chg30d=-0.42% | Revisions=+40% | GrowthEPS=-42.8% | GrowthRev=-15.7%
[Analyst] Revisions Ratio: +36% (up=6, down=2)